[1] CLEMMENSEN I, PETERSEN L C, KLUFT C. Purification and characterization of a novel, oligomeric, plasminogen Kringle 4 binding protein from human plasma:tetranectin[J]. European Journal of Biochemistry, 1986, 156(2):327-333.
[2] THOUGAARD A V, JALIASHVILI I, CHRISTIANSEN M. Tetranectin-like protein in vertebrate serum:a comparative immunochemical analysis[J]. Comparative Biochemistry and Physiology Part B, Biochemistry&Molecular Biology, 2001, 128(4):625-634.
[3] HO J E, LYASS A, COURCHESNE P, et al. Protein biomarkers of cardiovascular disease and mortality in the community[J]. Journal of the American Heart Association,2018, 7(14):e008108.
[4] MCDONALD K, GLEZEVA N, COLLIER P, et al. Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis[J]. Scientific Reports, 2020, 10:7507.
[5] LIU M, ECKERSALL P D, MRLJAK V, et al. Novel biomarkers in cats with congestive heart failure due to primary cardiomyopathy[J]. Journal of Proteomics, 2020,226:103896.
[6] WEWER U M, IBARAKI K, SCHJØRRING P, et al. A potential role for tetranectin in mineralization during osteogenesis[J]. The Journal of Cell Biology, 1994, 127(6 Pt 1):1767-1775.
[7] DAI W, WANG Y, YANG T, et al. Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals[J]. Cell Communication and Signaling, 2019, 17(1):113.
[8] ELEGHEERT J, BEHIELS E, BISHOP B, et al. Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins[J]. Nature Protocols, 2018, 13:2991-3017.
[9] LORENTSEN R H, GRAVERSEN J H, CATERER N R,et al. The heparin-binding site in tetranectin is located in the N-terminal region and binding does not involve the carbohydrate recognition domain[J]. The Biochemical Journal, 2000, 347(Pt 1):83-87.
[10] MOGUES T, ETZERODT M, HALL C, et al. Tetranectin binds to the Kringle 1-4 form of angiostatin and modifies its functional activity[J]. Journal of Biomedicine&Biotechnology, 2004, 2004(2):73-78.
[11] CHEN Y, HAN H, YAN X, et al. Tetranectin as a potential biomarker for stable coronary artery disease[J]. Scientific Reports, 2015, 5:17632.
[12] PATERSON C W, FORD M L, COOPERSMITH C M.Breaking the bond between tetranectin and HMGB1 in sepsis[J]. Science Translational Medicine, 2020, 12(539):eabb2575.
[13] WESTERGAARD U B, ANDERSEN M H, HEEGAARD C W, et al. Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator[J]. European Journal of Biochemistry, 2003, 270(8):1850-1854.
[14] ZHOU R, MAWATARI G, CAI X B, et al. CLEC3B is a novel causative gene for macular-retinal dystrophy[J]. Genetics in Medicine:Official Journal of the American College of Medical Genetics, 2022, 24(6):1249-1260.
[15] 贺帅杰,王小娟,穆永,等.猫CD3单克隆抗体的筛选与鉴定[J]. 中国兽医科学, 2023, 53(5):594-601.
[16] MALM M, KUO C C, BARZADD M M, et al. Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins[J]. Metabolic Engineering, 2022, 72:171-187.
[17] BEHIELS E, ELEGHEERT J. High-level production of recombinant eukaryotic proteins from mammalian cells using lentivirus[J]. Methods in Molecular Biology, 2021,2305:83-104.
[18] MAO Y, YAN R, LI A, et al. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells[J]. International Journal of Medical Sciences, 2015, 12(5):407-415.
[19] HE X, HE Q, YU W, et al. Optimized protocol for hightiter lentivirus production and transduction of primary fibroblasts[J]. Journal of Basic Microbiology, 2021,61(5):430-442.